Auyang Robotics’ debut; one subscription can earn 470,000 yuan 😱😱😱
So is it a robot leader, or is it a celebrity stock that’s been pushed up by emotions?
Auyang’s offering price is 150.80 yuan per share. Its offering market value is about 61 billion yuan. On its first trading day, the stock surged several times, with its market cap climbing to nearly $53 billion.
With this kind of jump, investors are trading not only for current performance, but for: → humanoid robots → domestic substitution → the AI industry chain → China’s robot leader. But a good company doesn’t necessarily mean a good price.
Auyang’s advantages are not just that it can build robot dogs. It has already laid out robot dogs, humanoid robots, and agile robotic arms, covering consumer markets, research and education, industrial applications, and the developer market.
Especially for robot dogs: their prices are relatively lower than overseas competitors, and they are also closer to real commercial deployment. At the very least, it proves it’s not only “able to build,” but also has a certain level of sales and delivery capability.
Auyang’s real technical barrier lies in motion control: running, jumping, flipping, walking on complex terrain, handling loads, and ensuring stability. Behind it are challenges in motors, reducers, control algorithms, sensor fusion, and system tuning.
Add to that its frequent “going viral,” and Auyang has formed brand and traffic advantages: products go viral → capital and order attention → increased R&D investment → continuous product iteration.
However, flipping tricks doesn’t mean it can reliably work in a factory for eight hours. Being able to perform on stage also doesn’t mean customers are already willing to place large-scale orders.
What really matters next is whether orders can keep growing, whether gross margin can hold after mass production, whether after-sales repair costs are high, and whether humanoid robots have batch customers.
The robot dog business is relatively mature, but the market space still needs to be observed. Humanoid robots have even greater imagination space, but they are still farther from large-scale commercialization.
So Auyang is: product capability leads, brand advantages are clear, and industry potential is huge—but the valuation has already priced in a significant portion of future expectations.
After the stock’s explosive surge on its listing day, I won’t just chase it blindly out of fear of missing out. In the short term, focus on the follow-through after the sentiment cools; in the mid term, look at orders, revenue, and profit; in the long term, see whether it can shift from “selling robot hardware” to “selling robot systems and solutions.”
Auyang is worth researching, but don’t just look at the press conference and robot performances. A good company and a good price have never been the same thing!😄😄$BTW $RICE $ACE
So is it a robot leader, or is it a celebrity stock that’s been pushed up by emotions?
Auyang’s offering price is 150.80 yuan per share. Its offering market value is about 61 billion yuan. On its first trading day, the stock surged several times, with its market cap climbing to nearly $53 billion.
With this kind of jump, investors are trading not only for current performance, but for: → humanoid robots → domestic substitution → the AI industry chain → China’s robot leader. But a good company doesn’t necessarily mean a good price.
Auyang’s advantages are not just that it can build robot dogs. It has already laid out robot dogs, humanoid robots, and agile robotic arms, covering consumer markets, research and education, industrial applications, and the developer market.
Especially for robot dogs: their prices are relatively lower than overseas competitors, and they are also closer to real commercial deployment. At the very least, it proves it’s not only “able to build,” but also has a certain level of sales and delivery capability.
Auyang’s real technical barrier lies in motion control: running, jumping, flipping, walking on complex terrain, handling loads, and ensuring stability. Behind it are challenges in motors, reducers, control algorithms, sensor fusion, and system tuning.
Add to that its frequent “going viral,” and Auyang has formed brand and traffic advantages: products go viral → capital and order attention → increased R&D investment → continuous product iteration.
However, flipping tricks doesn’t mean it can reliably work in a factory for eight hours. Being able to perform on stage also doesn’t mean customers are already willing to place large-scale orders.
What really matters next is whether orders can keep growing, whether gross margin can hold after mass production, whether after-sales repair costs are high, and whether humanoid robots have batch customers.
The robot dog business is relatively mature, but the market space still needs to be observed. Humanoid robots have even greater imagination space, but they are still farther from large-scale commercialization.
So Auyang is: product capability leads, brand advantages are clear, and industry potential is huge—but the valuation has already priced in a significant portion of future expectations.
After the stock’s explosive surge on its listing day, I won’t just chase it blindly out of fear of missing out. In the short term, focus on the follow-through after the sentiment cools; in the mid term, look at orders, revenue, and profit; in the long term, see whether it can shift from “selling robot hardware” to “selling robot systems and solutions.”
Auyang is worth researching, but don’t just look at the press conference and robot performances. A good company and a good price have never been the same thing!😄😄$BTW $RICE $ACE
